Replies to post #667135 on NorthWest Biotherapeutics Inc (NWBO)

[TTsr]

Absolutely, but I would even extend that to Big Co/Big Co… Amgen owns their MAB for severe asthma, and AZ is co-promoting it in the US, sharing revenues. I think it be smart for NWBO to hold onto all IP while allowing revenue generation for partners who are promoting/marketing it. I think its a win-win for both sides

[TTsr]

Imo NW is obviously in a VERY STRONG position… once approval - and let’s say it’s all glioma and eventually tumor agnostic - how much promotion will they need? They’ll still need boots on the ground to help coordinate patient access & acquisition to/from manufacturing to offices/hospitals, but that’s where the BPs with already established Onc sales teams come in.